The EMJ Podcast | Bonus Episode
This two-part podcast series delves into vitiligo as a systemic disease, its known risk factors, and the stigma often associated with the condition.
Featuring experts Amit G. Pandya, University of Texas Southwestern Medical Centre, Dallas, USA, and Thierry Passeron, Université Côte d’Azur, Nice, France, this podcast series also discusses the goals to consider in the management of patients with vitiligo, and the levels of patient satisfaction associated with current treatment options.
Podcast 1: What is the impact of vitiligo disease
This episode focuses on the impact of vitiligo disease, including the psychological impact of this condition on patients; the experts consider key questions that are asked of new patients on their first visit; and covers some patient case study examples.
ABBV-AA-00332-MC, approved Dec2023
Spotify | Apple | Amazon Music | Download MP3 (09:05 mins)
Podcast 2: How can we best manage our patients with vitiligo
This episode focuses on patient management including how to set, manage, and track goals in the management of vitiligo patients. The experts consider key aspects when considering forming a treatment plan.
ABBV-AA-00334-MC, approved Dec2023
Spotify | Apple | Amazon Music | Download MP3 (24:17 mins)
This podcast was funded by AbbVie. The content of the podcast reflects the opinions of the speakers and does not necessarily reflect the views of AbbVie.
Additional insights on living with vitiligo are available in an informative infographic, ‘The Unmet Need for Patients with Vitiligo is High’, which gives an overview of the condition’s symptoms and their impact, whilst also highlighting the comorbidities and management gaps that patients with vitiligo may experience.
